Obesity continues to be a growing issue in the United States with an estimated prevalence of 72 million people. There are major health implications associated with obesity including its relationship with hypertension, diabetes mellitus type 2, the metabolic syndrome, and dyslipidemia, all independent risk factors for CAD. Despite the increased risk of developing CAD, in recent years an "obesity paradox" has been described in which moderately obese individuals with established cardiovascular disease, including CAD, appear to have mortality similar to their normal weight counterparts. This review discusses the relationship between obesity and CAD, including the increased risk of hypertension, diabetes mellitus, the metabolic syndrome, and dyslipidemia along with a discussion of the obesity paradox and the benefits of weight reduction.
Introduction
Obesity, defined as a body mass index (BMI) ≥30 kg/m 2 , constitutes a major problem in the United States (US) with an overall prevalence estimated at 72 million people. (1, 2) Due to the numerous health implications associated with obesity, it is currently estimated to be the second leading caused of preventable death. (2, 3) Obesity is associated with increased risk of hypertension (HTN), diabetes mellitus type 2 (DM), the metabolic syndrome (MetS), and dyslipidemia, all risk factors for coronary artery disease (CAD). (4, 5) Obesity, however, is not homogeneous in its effect, with a subset of obese individuals that are relatively insulin sensitive, labeled metabolically healthy obese (MHO), who have a more favorable cardiovascular (CV) profile compared to insulin-resistant obese (IRO) individuals. (6) (7) (8) (9) (10) (11) The relationship between obesity and CAD is further complicated by the idea of the "obesity paradox" where mildly obese individuals have similar or lower mortality to their normal weight counterparts. This review discusses the relationship of obesity and CAD, including the possible mechanisms through which obesity increases CAD risk, the MHO individuals, along with a discussion of the "obesity paradox" in CAD and its implications in patient management including weight loss.
Obesity and its association with CAD risk factors
Obesity is associated with increased risk of HTN, DM, MetS, and dyslipidemia. (4, 5) Through its affect on these diseases, obesity increases the risk of developing CAD. In the following section we describe the relationship between obesity and CAD. (14) The mechanism for the association between obesity and HTN is likely multifactorial. (Table 1 ) Through the production of angiotensin, a precursor of the renin-angiotensin-aldosterone system, adipose cells have a endocrine effect on a known pathway for the pathogenesis of HTN. (15) Beyond adipose cell's endocrine effect, there is an increase in circulating blood volume and total peripheral resistance seen with increasing BMI, which may lead to HTN. (16) Obesity is an independent risk factor for both DM and MetS, with the prevalence of DM being closely related to the rise in obesity. (17, 18) The Behavioral Risk Factor Surveillance System demonstrated that the prevalence of DM increased 33% throughout follow up, a rise related with increasing rates of obesity.(18) DM increases the risk of CAD through its association with endothelial dysfunction and dyslipidemias, both initial steps in the atherogenic process. (Table 1 ) Through these mechanisms, DM is one of the strongest CAD risk factors, characterized by very high 10-year risk of CV events. (15, 19) Additionally, DM is a common cause of renal dysfunction, an independent risk factor for CAD. 
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The obesity paradox
Despite the increased risk of developing CAD and its risk factors, epidemiologic data from recent years has described an "obesity paradox". The obesity paradox refers to the finding that despite an increased risk of developing CVD in the obese, once CVD has been established, overweight and mildly obese individuals may have a decreased or similar M A N U S C R I P T
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outcomes and mortality compared to their normal weight counterparts. This paradox has been described in a number of CV diseases such as CAD, heart failure, and atrial fibrillation (1, 5, (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) , though conflicting data exists in the literature among certain subgroups of CAD individuals. (35, 44, 45) The following is a discussion of the obesity paradox in CAD cohorts and its implication.
There are numerous studies describing the obesity paradox in CAD in a variety of cohorts including hospitalized registries (46, 47) (Figure 1 ) This systematic review and meta-analysis by Romero-Corral is important in the discussion of obesity and CAD as it demonstrates that obese patients do not have a significantly higher risk unless further stratified as moderate obese and morbid obesity. Furthermore, only CV mortality is worsened among the severely obese. What was not seen was an inverse association between obesity and death in patients with CAD, and thus caution should be used in discounting obesity as a risk factor for CAD progression and complications.
Potential mechanisms for the obesity paradox
While the mechanism for the potential protective effect of obesity among those with CAD 
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illness, or having a shorter duration of follow up than is optimal which may both affect the ability to be fit while also affecting CV mortality. Despite the findings of the obesity paradox, current data does not support increasing weight among individuals with CAD, but appear to indicate that fitness is an important part of preventing obesity. (56, (72) (73) (74) (75) (76) 
Weight loss and CAD
While obesity appears to demonstrate improved mortality benefit in those with CAD, there is still significant evidence supporting weight loss as a way to reverse CAD risk factors, including HTN, DM, and dyslipidemia and potentially reduce mortality. (36, 74, 75, (77) (78) (79) (80) (81) (82) (83) (84) (85) (86) Weight loss has been associated with marked improvements in arterial pressure and LV geometry, potentially improving HTN. (86) Additionally, exercise, a potential tool for weight loss, has been associated with increases in cardioprotective HDL-C, increased insulin sensitivity, and a decrease in the prevalence of MetS and DM. (78) (79) (80) Weight loss also appears to impact mortality in CAD. (36, 
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Despite these findings, others have described increased mortality with weight loss (87) and the benefit of weight loss, except among the morbidly obese, is unclear. (1, (88) (89) (90) What is certain is that fitness is important to improve prognosis among CAD patients (81) (82) (83) and, therefore, physical activity, exercise training and fitness improvements, with potentially accompanying purposeful weight loss, should be incorporated into treatment plans of overweight or obese patients with CAD. (84, 85) 
Conclusion
Obesity is related to multiple risk factors of CAD including HTN, DM, MetS, and dyslipidemia, while also likely being an independent risk factor for CAD. Through multiple pathways including increased angiotensin, circulating blood volume, and total peripheral resistance excess weight increases HTN risk. Figure 3 . 9,563 subjects with known or suspected coronary heart disease stratified by body mass index (BMI) category (A), waist circumference (WC), and body fat percent (BF) tertiles ((B) and (C) respectively) on all cause mortality. Normal BMI, low WC and low BF in the high fitness group were used as reference groups. Hazard ratios (boxes) and 95% confidence intervals (error bars represent values) after adjusting for age, baseline examination year, physical activity, smoking hyperlipidemia, diabetes and family history of cardiovascular disease. Reproduced with permission from McAuley et al. (65) 
